iTrack™ Advance: Lighting the Way in Canaloplasty скачать в хорошем качестве

iTrack™ Advance: Lighting the Way in Canaloplasty

Inspired by the success and methodology of modern angioplasty, Nova Eye pioneered canaloplasty for glaucoma in 2008 with the launch of the rigorously tested iTrack™ procedure, which combines 360° catheterization and pressurized viscodilation to treat all points of outflow resistance. Stent-free and tissue-preserving, canaloplasty can help glaucoma surgeons, comprehensive ophthalmologists and cataract specialists effectively reduce IOP in cases of mild to moderate glaucoma, while preserving the viability of future treatment options. As a 360° procedure that addresses the entire conventional outflow pathway, including the trabecular meshwork, Schlemm’s canal and the collector channels, iTrack™ Advance literally treats glaucoma from all angles. What’s more, iTrack™ Advance is cleared for use as a standalone procedure and in combination with cataract surgery. Learn more here: https://itrack-advance.com -------------------------------------------------------- The iTrack™ Advance has a US Food and Drug Administration (FDA) 510(k) and CE Mark (Conformité Européenne) for the treatment of open-angle glaucoma. Indications for Use, USA: The iTrack™ Advance is indicated for fluid infusion or aspiration during surgery. The iTrack™ Advance is indicated for the cutting or disruption of the trabecular meshwork during goniotomy procedures.* The iTrack™ Advance is indicated for catheterization and viscodilation of Schlemm’s canal to reduce intraocular pressure in adult patients with open-angle glaucoma. The ab interno surgical technique is not a cleared indication for the iTrack™ Advance in the USA. The iTrack™ Advance cutting function (goniotomy) is a Class 1 510(k) exempt device function that is not specifically indicated for the reduction of intraocular pressure (IOP) or the treatment of open-angle glaucoma. Indications for Use, International: The iTrack™ Advance is indicated for fluid infusion or aspiration during surgery. The iTrack™ Advance is indicated for catheterization and viscodilation of Schlemm’s canal to reduce intraocular pressure in adult patients with open-angle glaucoma. For more information in relation to approved labelling and indications for use, please visit https://itrack-advance.com/